Human Medicines European Public Assessment Report (EPAR): Imbruvica, Ibrutinib, Lymphoma, Mantle-Cell,Leukemia, Lymphocytic, Chronic, B-Cell, Date of Authorisation: 21/10/2014, Revision: 13, Status: Authorised

Case Medical Research
doi 10.31525/cmr-12043eb
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): Arzerra, Ofatumumab, Leukemia, Lymphocytic, Chronic, B-Cell, Date of Authorisation: 19/04/2010, Revision: 16, Status: Withdrawn

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Pregabalin Pfizer, Pregabalin, Anxiety Disorders,Epilepsy, Date of Authorisation: 10/04/2014, Revision: 13, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Tadalafil Mylan, Tadalafil, Erectile Dysfunction, Date of Authorisation: 21/11/2014, Revision: 8, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Xyrem, Sodium Oxybate, Cataplexy,Narcolepsy, Date of Authorisation: 13/10/2005, Revision: 29, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Revlimid, Lenalidomide, Multiple Myeloma,Lymphoma, Mantle-Cell,Myelodysplastic Syndromes, Date of Authorisation: 14/06/2007, Revision: 37, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Colobreathe, Colistimethate Sodium, Cystic Fibrosis, Date of Authorisation: 13/02/2012, Revision: 10, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Bronchitol, Mannitol, Cystic Fibrosis, Date of Authorisation: 13/04/2012, Revision: 13, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Pixuvri, Pixantrone Dimaleate, Lymphoma, Non-Hodgkin, Date of Authorisation: 10/05/2012, Revision: 19, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Instanyl, Fentanyl, Pain,Cancer, Date of Authorisation: 20/07/2009, Revision: 21, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy